advanc
age
risk
factor
sever
acut
respiratori
syndrom
sar
human
understand
pathogenesi
develop
anim
model
use
balbc
mice
mousepassag
frankfurt
isol
sar
coronaviru
sarscov
examin
immun
respons
sarscov
young
adult
mice
sarscov
induc
sever
respiratori
ill
adult
young
mice
day
inocul
mortal
rate
moribund
adult
mice
show
sever
pulmonari
edema
diffus
alveolar
damag
accompani
viru
replic
adult
murin
lung
significantli
higher
interleukin
il
lower
level
infect
young
murin
lung
rapidli
produc
high
level
proinflammatori
chemokin
cytokin
known
induc
macrophag
neutrophil
infiltr
activ
eg
tumor
necrosi
day
inocul
young
murin
lung
produc
proinflammatori
cytokin
also
adult
mice
show
earli
acut
excess
proinflammatori
respons
ie
cytokin
storm
lung
sarscov
infect
led
sever
pulmonari
edema
diffus
alveolar
damag
intraven
inject
antitumor
necrosi
antibodi
hour
infect
effect
sarscov
infect
howev
intraperiton
inject
protect
adult
mice
lethal
respiratori
ill
experiment
model
describ
may
use
elucid
pathophysiolog
sar
evalu
therapi
treat
sarscov
infect
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
epidem
winter
peopl
sar
patient
suffer
progress
respiratori
failur
die
common
symptom
sar
includ
fever
nonproduct
cough
myalgia
dyspnea
age
year
older
comorbid
diseas
male
sex
high
neutrophil
count
sever
biochem
abnorm
associ
poor
outcom
sarscov
spike
protein
mediat
infect
cell
bear
appropri
receptor
one
receptor
angiotensinconvert
enzym
bind
sarscov
protein
high
affin
bind
sarscov
may
contribut
sarscovassoci
patholog
suggest
sever
report
show
angiotensin
ii
express
promot
sever
lung
failur
acut
lung
injuri
wherea
express
protect
lung
injuri
howev
like
acut
lung
injuri
caus
sarscov
infect
also
attribut
complex
pathophysiolog
process
inflammatori
cytokin
releas
activ
alveoli
macrophag
induc
immun
system
dysregul
understand
pathogenesi
sarscov
sarscov
suscept
experiment
anim
monkey
cat
ferret
mice
pig
guinea
pig
hamster
chicken
rat
investig
anim
suscept
sarscov
intrarespiratori
inocul
exhibit
viru
excret
pharyng
nasal
swab
histopatholog
pulmonari
lesion
seroconvers
howev
cours
infect
anim
shorter
human
human
advanc
age
correl
posit
independ
advers
outcom
predictor
mortal
anim
model
moreov
sarscov
isol
replic
better
age
balbc
mice
younger
mice
like
correl
poor
outcom
advanc
age
reflect
weaken
immun
respons
elderli
particular
impair
cytokin
respons
signific
cytokin
regul
immun
respons
infect
inde
analysi
cytokin
respons
elderli
individu
respiratori
infect
lead
sever
pulmonari
diseas
eg
listeria
monocytogen
respiratori
syncyti
viru
influenza
viru
reveal
unbalanc
respons
recent
succeed
establish
rat
model
sar
use
ratpassag
sarscov
although
ratpassag
sarscov
lethal
induc
sever
patholog
lesion
adult
rat
young
rat
found
sever
inflamm
adult
rat
associ
high
level
inflammatori
cytokin
serum
lung
homogen
especi
interleukin
il
along
low
level
immunosuppress
cytokin
inflammatori
cytokin
produc
monocyt
leukocyt
endotheli
cell
fibroblast
alveolar
epitheli
cell
sar
patient
significantli
elev
serum
level
produc
macrophag
lymphocyt
b
cell
inhibit
tumor
necrosi
factor
tnf
product
neutrophil
activ
lipopolysaccharideinduc
acut
lung
injuri
therebi
suppress
lung
tissu
injuri
report
serum
level
increas
sar
patient
convalesc
phase
studi
establish
new
use
experiment
small
anim
model
sar
use
balbc
mice
mousepassag
sarscov
model
allow
us
better
character
virushost
relationship
determin
immun
respons
antivir
pathogen
sought
determin
sarscov
infect
frequent
lethal
elderli
patient
compar
sarscovinfect
adult
young
mice
term
pulmonari
patholog
immun
respons
frankfurt
isol
sarscov
use
studi
kindli
suppli
dr
john
ziebuhr
institut
virolog
immunolog
univers
rzburg
rzburg
germani
viru
propag
twice
vero
cell
purchas
american
type
cell
collect
manassa
va
cultur
eagl
minim
essenti
medium
mem
contain
fetal
bovin
serum
iu
penicillin
g
g
streptomycin
per
ml
titer
stock
viru
express
tissu
cultur
infecti
dose
tcid
ml
vero
cell
calcul
accord
rber
method
work
infecti
sarscov
perform
biosafeti
level
condit
compar
origin
viru
frankfurt
isol
use
laboratori
one
amino
acid
chang
posit
tyr
protein
anoth
open
read
frame
orf
ala
ser
chang
presum
aros
passag
vero
cell
femal
balbc
mice
purchas
japan
slc
shizuoka
japan
maintain
specif
pathogenfre
facil
experiment
infect
anim
hous
biosafeti
level
anim
facil
anim
experi
approv
anim
care
use
committe
nation
institut
infecti
diseas
tokyo
japan
frankfurt
isol
sarscov
serial
passag
time
femal
balbc
mice
follow
intranas
inocul
three
mice
sacrif
day
inocul
bronchoalveolar
wash
fluid
collect
bronchoalveolar
fluid
use
inocul
three
addit
balbc
mice
whose
bronchoalveolar
fluid
day
inocul
use
inocul
fresh
mice
passag
mice
lung
remov
steril
condit
wash
three
time
homogen
ml
phosphat
buffer
contain
bovin
serum
albumin
iu
penicillin
g
l
streptomycin
g
amphotericin
b
per
ml
lung
homogen
centrifug
g
minut
ml
supernat
ml
mem
contain
fetal
bovin
serum
use
infect
vero
cell
hour
adsorpt
inoculum
remov
mem
contain
fetal
bovin
serum
ad
cell
cultur
incub
co
day
treat
freezethaw
centrifug
g
minut
supernat
refer
use
viru
inoculum
compar
origin
viru
amino
acid
mutat
protein
posit
asp
glu
tyr
latter
chang
ident
one
mutat
found
frankfurt
isol
complet
sequenc
genom
also
two
addit
mutat
phe
leu
thr
ile
mutat
found
frankfurt
isol
present
mice
anesthet
intraperiton
inject
g
bodi
weight
mixtur
mg
ketamin
mg
xylazin
anim
inocul
intranas
left
nostril
frankfurt
isol
tcid
l
observ
clinic
sign
bodi
weight
measur
daili
day
infect
anim
also
sacrif
variou
time
point
inocul
analyz
viru
replic
hematolog
cytokin
express
patholog
n
group
twenti
percent
wv
tissu
homogen
lung
maxilla
includ
nasal
caviti
cervic
lymph
node
spleen
liver
kidney
prepar
mem
contain
fetal
bovin
serum
iu
penicillin
g
g
streptomycin
g
amphotericin
b
per
ml
bronchoalveolar
nasal
wash
fluid
also
collect
analysi
viru
replic
viral
infect
titer
respiratori
tract
wash
fluid
determin
describ
viru
isol
tissu
perform
blind
passag
freez
thaw
firstround
passag
use
vero
cell
total
blood
cell
count
peripher
blood
collect
sodiumheparin
tube
measur
autoanalyz
cell
tuck
nihon
koden
tokyo
japan
neutrophil
lymphocyt
monocyt
eosinophil
basophil
count
determin
microscop
analysi
antibodi
use
flow
cytometri
ebiosci
san
diego
ca
santa
cruz
biotechnolog
santa
cruz
ca
antipannk
cellsfluorescein
isothiocyan
ebiosci
cell
incub
surfacebind
antibodi
fix
paraformaldehyd
phosphatebuff
salin
pb
subject
flow
cytometri
epic
elit
beckman
coulter
fullerton
ca
use
expo
cytomet
softwar
beckman
coulter
homogen
lung
tissu
sampl
dilut
cell
extract
buffer
mmoll
tri
ph
mmoll
nacl
mmoll
edta
mmoll
egta
mmoll
naf
mmoll
na
p
mmoll
na
vo
triton
glycerol
sodium
dodecyl
sulfat
deoxychol
biosourc
intern
inc
camarillo
ca
incub
minut
ice
vortex
minut
interv
centrifug
g
minut
supernat
dilut
assay
diluent
mous
cytokin
antibodi
bead
kit
biosourc
intern
sera
lung
homogen
supernat
subject
ultraviolet
irradi
minut
inactiv
viru
infect
store
use
determin
presenc
mous
cytokin
name
basic
fibroblast
growth
factor
gmcsf
interferon
ifn
keratinocyt
chemoattract
kc
monocyt
chemoattract
protein
mig
vascular
endotheli
growth
factor
vegf
use
mous
cytokin
antibodi
bead
kit
luminex
luminex
co
austin
tx
anim
n
group
anesthet
perfus
ml
phosphatebuff
formalin
fix
lung
heart
kidney
liver
spleen
small
larg
intestin
brain
spinal
cord
maxilla
includ
nasal
caviti
tissu
routin
embed
paraffin
section
stain
hematoxylin
eosin
maxilla
sampl
decalcifi
phosphatebuff
salin
ph
plu
edta
embed
immunohistochem
detect
sarscov
antigen
perform
paraffinembed
section
follow
deparaffin
xylen
section
rehydr
ethanol
immers
pb
antigen
retriev
hydrolyt
autoclav
minut
mmoll
sodium
citratesodium
chlorid
buffer
ph
cool
section
immers
pb
endogen
peroxidas
block
incub
hydrogen
peroxid
methanol
minut
wash
pb
section
incub
normal
rabbit
serum
minut
rabbit
antibodi
sarscov
overnight
three
wash
pb
section
incub
biotinconjug
antirabbit
igg
minut
follow
reaction
streptavidinperoxidas
minut
room
temperatur
peroxidas
activ
detect
develop
diaminobenzidin
contain
hydrogen
peroxid
nuclei
counterstain
hematoxylin
sarscovand
mockinfect
adult
young
mice
euthan
day
inocul
exsanguin
excess
ether
anesthesia
lung
harvest
patholog
examin
three
mice
per
group
mock
infect
perform
use
mem
contain
fetal
bovin
serum
stain
antisurfact
spd
antibodi
detect
sarscov
antigen
lung
fix
paraformaldehyd
pb
hour
embed
paraffin
accord
manufactur
instruct
bd
bioscienc
pharmingen
san
diego
ca
paraffinembed
section
subject
doubleimmunofluoresc
stain
method
use
polyclon
rabbit
antibodi
sarscov
monoclon
mous
antibodi
nucleocapsid
protein
monoclon
rat
antibodi
mous
mononuclear
phagocyt
bd
bioscienc
pharmingen
polyclon
rabbit
antispd
antibodi
chemicon
intern
inc
billerica
briefli
deparaffin
xylen
section
rehydr
ethanol
immers
pb
antigen
retriev
hydrolyt
autoclav
minut
mmoll
sodium
citratesodium
chlorid
buffer
ph
cool
section
immers
pb
incub
primari
antibodi
overnight
block
background
stain
normal
donkey
serum
mom
immunodetect
kit
primari
mous
monoclon
antibodi
vector
laboratori
burlingam
ca
use
accord
manufactur
instruct
three
wash
pb
section
incub
minut
biotinconjug
secondari
antibodi
ie
donkey
antirat
serum
jackson
immunoresearch
west
grove
pa
detect
antibodi
goat
antirabbit
serum
jackson
immunoresearch
detect
spd
antibodi
three
wash
pb
section
incub
streptavidinalexa
fluor
molecular
probe
eugen
minut
room
temperatur
three
wash
pb
detect
sarscov
antibodi
rabbit
antibodi
section
incub
antirabbit
antimous
alexa
fluor
molecular
probe
minut
room
temperatur
section
counterstain
nucleic
acid
stain
molecular
probe
imag
captur
analyz
confoc
laser
microscopi
fluoview
olympu
tokyo
japan
three
hour
intranas
inocul
tcid
l
adult
balbc
femal
mice
inject
intraven
l
antimous
rat
monoclon
antibodi
gl
biosourc
isotypematch
control
rat
antibodi
gl
mp
biomed
solon
oh
pb
inject
intraperiton
l
recombin
mous
gl
r
system
minneapoli
mn
intraperiton
inject
l
bovin
serum
albumin
use
control
least
two
independ
experi
perform
n
per
group
sarscovand
mockinfect
mice
inject
intraven
l
evan
blue
dye
tokyo
kasei
tokyo
japan
hour
sacrific
n
group
mock
infect
perform
use
mem
contain
fetal
bovin
serum
perfus
isoton
salin
whole
lung
remov
immers
phosphatebuff
formalin
fix
lung
immedi
frozen
cold
aceton
dri
ice
oct
compound
sakura
finetechn
co
ltd
tokyo
japan
cryosect
leica
wetzlar
germani
mount
mascoat
slide
matsunami
osaka
japan
airdri
examin
fluoresc
microscop
statist
signific
determin
student
ttest
p
valu
consid
signific
frankfurt
isol
passag
twice
cell
serial
passag
time
young
balbc
mice
femal
intranas
inocul
bronchoalveolar
fluid
infect
mice
strain
show
higher
replic
pathogen
respiratori
tract
young
balbc
mice
origin
frankfurt
isol
follow
figur
ae
day
inocul
replic
lung
wash
higher
origin
frankfurt
isol
p
lower
nasal
wash
p
figur
compar
frankfurt
isolateinocul
young
mice
young
mice
also
evinc
lung
inflamm
shown
neutrophil
macrophag
lymphocyt
infiltr
viru
antigenposit
cell
alveolar
space
figur
howev
young
mice
develop
obviou
respiratori
ill
although
show
transient
weight
loss
day
inocul
data
shown
advanc
age
associ
higher
mortal
human
sar
patient
sarscov
replic
better
age
mice
experiment
infect
adult
femal
balbc
mice
frankfurt
isol
although
none
mice
show
clinic
sign
ill
intranas
inocul
frankfurt
isol
mice
becam
sever
ill
reveal
signific
weight
loss
initi
bodi
weight
hunch
ruffl
fur
dyspnea
day
inocul
figur
three
ten
mice
becam
moribund
die
sever
respiratori
ill
day
inocul
mortal
rate
surviv
anim
recov
bodi
weight
day
inocul
result
demonstr
serial
vivo
passag
sarscov
mice
increas
virul
viru
especi
adult
mice
thu
character
clinic
patholog
featur
young
adult
mice
day
inocul
detail
young
mice
show
transient
weight
loss
sd
day
inocul
recov
weight
day
inocul
figur
contrast
adult
mice
show
continu
weight
loss
sd
initi
bodi
weight
continu
day
inocul
adult
mice
show
virtual
ident
clinic
manifest
day
inocul
hunch
ruffl
fur
observ
young
mice
sever
respiratori
symptom
dyspnea
also
observ
adult
mice
day
inocul
onward
experi
adult
mice
die
day
inocul
lung
infect
young
adult
mice
weigh
day
inocul
progress
increas
lung
weight
adult
mice
suggest
develop
pulmonari
edema
figur
b
c
day
inocul
adult
show
significantli
greater
lung
weight
chang
young
mice
p
lung
infect
young
adult
mice
also
subject
histopatholog
analysi
day
inocul
figur
ah
day
inocul
young
adult
mice
antigenposit
epitheli
cell
bronchi
alveoli
antigenposit
cell
alveoli
consid
base
morpholog
immunohistochemistri
mainli
type
ii
pneumocyt
figur
e
see
supplement
figur
http
ajpamjpatholorg
day
inocul
antigenposit
atroph
necrot
cell
seen
alveolar
area
mice
figur
addit
antigenposit
activ
alveolar
macrophag
associ
inflammatori
infiltr
seen
alveolar
area
adult
mice
figur
antigenposit
cell
seen
bronchi
day
inocul
afterward
either
young
adult
mice
day
inocul
young
mice
diffus
inflammatori
infiltr
consist
mainli
mononuclear
cell
figur
c
viru
antigenposit
cell
seen
alveolar
area
activ
macrophag
lymphocyt
neutrophil
seen
alveoli
day
inocul
contrast
adult
mice
evinc
sever
pulmonari
edema
congest
day
inocul
figur
g
h
mice
main
inflammatori
cell
around
adult
blood
vessel
alveolar
area
day
inocul
neutrophil
activ
macrophag
fibrin
deposit
hyalin
membran
format
alveolar
duct
alveoli
also
observ
figur
microhemorrhag
seen
alveolar
area
adult
mice
also
high
viru
titer
lung
maxilla
includ
nasal
caviti
fluid
figur
e
infect
viru
continu
isol
cervic
lymph
node
spleen
liver
kidney
adult
mice
day
inocul
wherea
viru
could
longer
isol
young
mous
tissu
apart
lung
time
point
tabl
analyz
immun
respons
young
adult
mice
infect
examin
peripher
blood
white
blood
cell
count
figur
measur
level
differ
chemokin
cytokin
level
plasma
lung
homogen
figur
infect
day
adult
mice
significantli
lower
white
blood
cell
count
especi
regard
lymphocyt
includ
cell
lung
wash
fluid
lung
homogen
young
mice
day
inocul
n
per
group
detect
limit
tcid
g
tissu
asterisk
indic
statist
signific
differ
frankfurt
isol
p
histopatholog
featur
lung
young
mice
day
inocul
b
infect
frankfurt
isol
inflammatori
infiltr
lung
detect
moreov
alveolar
pneumocyt
alveolar
duct
alveolu
epitheli
cell
sarscov
antigenposit
c
arrowhead
contrast
extens
cellular
infiltr
mani
viru
antigenposit
cell
e
seen
alveolar
area
infect
f
clinic
ill
individu
adult
balbc
mice
frankfurt
isol
infect
n
per
group
shown
chang
bodi
weight
express
percentag
bodi
weight
day
mean
initi
bodi
weight
two
mous
group
day
g
g
respect
signific
differ
bodi
weight
chang
detect
day
inocul
exampl
averag
bodi
weight
adult
mice
day
inocul
mean
day
bodi
weight
significantli
lower
averag
bodi
weight
chang
frankfurt
isolateinfect
adult
mice
day
inocul
three
adult
mice
die
cross
sever
pulmonari
edema
day
inocul
young
mice
figur
infect
neutrophil
count
adult
mice
increas
howev
chang
observ
young
mice
young
mice
rel
count
day
lymphocyt
count
decreas
significantli
p
day
inocul
recov
tcell
count
decreas
significantli
day
recov
tcell
count
decreas
slightli
show
signific
assess
lung
pulmonari
edema
lung
weigh
mice
sacrif
day
inocul
exsanguin
anesthesia
n
per
group
c
lung
virusand
mockinfect
young
adult
mice
obtain
indic
time
point
inocul
arrowhead
indic
focal
congest
day
increas
day
contrast
although
lymphocyt
count
adult
mice
also
drop
significantli
lower
day
count
day
evid
improv
day
inocul
moreov
tand
tcell
count
adult
mice
also
show
signific
drop
day
inocul
p
recov
poorli
day
inocul
unlik
count
young
mice
regard
pannk
cell
count
young
adult
mice
show
mark
drop
day
inocul
follow
brief
recoveri
anoth
loss
day
inocul
cell
count
loss
day
day
inocul
compar
day
inocul
adult
mice
p
regard
cytokin
respons
mice
lung
homogen
adult
mice
day
inocul
significantli
higher
level
monocyterel
chemokin
ie
macrophag
inflammatori
protein
protein
young
mice
figur
contrast
day
inocul
lung
homogen
young
mice
exhibit
elev
level
three
cytokin
well
kc
monokin
induc
mig
vascular
endotheli
growth
factor
vegf
figur
compar
young
mice
lung
homogen
adult
mice
day
inocul
also
higher
level
day
inocul
higher
level
day
day
observ
figur
contrast
lung
homogen
young
mice
significantli
higher
level
day
inocul
day
inocul
day
inocul
day
inocul
notabl
lung
homogen
preinfect
adult
mice
day
higher
lower
level
young
murin
lung
observ
indic
pattern
cytokinechemokin
respons
differ
young
adult
mice
sarscov
infect
adult
mice
show
earli
acut
excess
proinflammatori
respons
lung
sarscov
infect
determin
whether
respons
adult
mice
produc
young
adult
mice
play
signific
role
develop
sarslik
ill
adult
mice
treat
adult
mice
antibodi
hour
infect
figur
b
although
intraven
inject
antibodi
delay
onset
weight
loss
infect
adult
mice
well
onset
respiratori
ill
antibodytr
control
adult
mice
show
signific
bodi
weight
loss
day
inocul
signific
differ
mortal
rate
treat
control
adult
mice
treat
adult
mice
mortal
rate
control
adult
mice
mortal
rate
two
separ
experi
figur
contrast
mice
rapidli
recov
ill
evidenc
bodi
weight
loss
sever
acut
respiratori
symptom
anim
surviv
onset
day
inocul
figur
contrast
control
adult
mice
die
asterisk
indic
statist
signific
higher
lower
chemokin
level
adult
mice
p
compar
young
balbc
mice
adult
mice
show
earlier
induct
lung
young
mice
three
chemokin
mig
vegf
significantli
higher
level
lung
young
mice
day
inocul
determin
whether
protect
effect
treatment
attribut
suppress
viral
replic
viru
titer
day
inocul
nasal
wash
maxilla
homogen
lung
wash
lung
homogen
pbstreat
adult
mice
infect
compar
howev
two
group
differ
significantli
term
viru
titer
respiratori
tract
figur
mice
show
much
milder
histopatholog
chang
untreat
mice
mild
edema
slight
mononuclear
cell
infiltr
observ
around
blood
vessel
infect
figur
contrast
pbstreat
mice
exhibit
sever
edema
infiltr
inflammatori
cell
mainli
neutrophil
around
blood
vessel
figur
examin
evan
blue
dye
extravas
found
mice
also
lower
blood
vessel
permeabl
pbstreat
mice
figur
ag
togeth
result
suggest
treatment
hour
inocul
protect
mice
sever
sarscovinduc
pulmonari
edema
respons
death
untreat
adult
mice
understand
better
pathogenesi
sar
sarscov
infect
develop
use
experiment
mous
model
sar
frankfurt
isol
sarscov
serial
passag
vivo
young
balbc
mice
passag
viru
exhibit
increas
infect
murin
lung
also
abl
induc
sever
sarslik
ill
adult
balbc
mice
sever
anim
die
sever
pulmonari
edema
acut
alveolar
damag
howev
young
mice
rel
resist
evinc
obviou
respiratori
ill
immun
respons
fect
young
adult
mice
compar
adult
anim
significantli
lower
preexist
lymphocyt
tcell
count
lung
express
significantli
higher
lower
level
infect
lung
show
strong
upregul
tcell
cytokin
exhibit
young
murin
lung
infect
infect
lung
adult
mice
also
produc
inflammatori
chemokinecytokinerel
macrophag
ie
earlier
young
mice
day
inocul
higher
level
also
higher
level
day
inocul
contrast
young
mice
produc
high
level
inflammatori
chemokin
cytokin
ie
kc
mig
vegf
day
inocul
produc
littl
time
point
observ
suggest
advancedag
balbc
mice
earli
acut
excess
proinflammatori
cytokin
reaction
ie
cytokin
storm
respons
cytokin
storm
result
sever
pulmonari
edema
macrophag
neutrophil
infiltr
caus
sever
acut
lung
injuri
like
caus
death
infect
adult
mice
support
scenario
report
agerel
differ
pulmonari
cytokin
chemokin
respons
pathogen
especi
cytokin
imbal
moreov
recent
report
show
unregul
ifn
respons
acut
sar
prevent
sarscovinfect
patient
switch
innat
adapt
immun
report
describ
may
respons
lung
immunopatholog
sar
patient
interestingli
model
inject
hour
inocul
significantli
reduc
acut
pulmonari
edema
induc
infect
notabl
protect
effect
inject
associ
reduct
viral
titer
lung
anim
model
human
result
seem
consist
howev
observ
togeth
suggest
failur
adult
anim
produc
promin
immunomodul
play
key
role
host
defens
intracellular
pathogen
respons
inabl
control
excess
pathogen
innat
immun
respons
viru
lung
support
previou
studi
rat
sar
model
show
although
adult
rat
develop
sever
inflammatori
reaction
led
pulmonari
edema
infect
anim
surviv
significantli
infect
adult
rat
similar
cytokin
profil
infect
adult
mice
except
also
produc
thu
strong
time
respons
may
need
prevent
immunopatholog
induc
sarscov
infect
regard
inflammatori
reaction
adult
lung
histopatholog
chemokinecytokin
analys
suggest
day
inocul
affect
respiratori
epitheli
cell
pulmonari
macrophag
releas
acut
inflammatori
chemokin
cytokin
thu
pulmonari
macrophag
activ
associ
releas
appear
predomin
earli
phase
inflammatori
reaction
adult
classic
acut
inflammatori
cytokin
recruit
neutrophil
monocyt
area
infect
along
increas
vascular
permeabl
activ
cell
erad
pathogen
howev
overexpress
induc
system
clinic
patholog
abnorm
depress
cardiac
dysfunct
cardiomyocyt
death
doubleedg
aspect
function
may
effect
neutral
antibodi
sarscov
infect
model
support
key
role
immunopatholog
lung
adult
mice
day
inocul
infiltr
predominantli
neutrophil
mice
also
exhibit
neutrophilia
young
mice
evinc
chang
suggest
infect
adult
mice
produc
induc
neutrophilmedi
inflamm
lung
although
signific
clear
high
neutrophil
infiltr
lung
known
caus
result
lung
injuri
character
hyalin
membran
format
pulmonari
edema
high
neutrophil
count
human
sar
case
also
associ
poor
outcom
observ
antibodi
experi
control
group
inject
hour
infect
rat
igg
serum
intraven
pb
intraperiton
show
bodi
weight
loss
start
day
inocul
contrast
untreat
mice
shown
figur
start
lose
weight
day
inocul
may
inject
serum
pb
infect
enhanc
pulmonari
edema
hyperperm
lung
previous
report
serial
vivo
passag
sarscov
rat
increas
infect
viru
rat
correl
singl
amino
acid
chang
viru
receptorbind
domain
protein
detect
similar
chang
along
anoth
amino
acid
chang
receptorbind
domain
protein
amino
acid
chang
may
respons
least
part
increas
replic
pulmonari
tissu
balbc
mice
use
anoth
sarscov
isol
urbani
robert
colleagu
describ
develop
character
mouseadapt
strain
lethal
young
femal
balbc
mice
intranas
inocul
compar
origin
urbani
isol
strain
six
code
mutat
may
respons
mous
adapt
increas
virul
strain
fewer
amino
acid
mutat
mouseadapt
strain
may
respons
fact
less
virul
conclus
develop
experiment
mous
anim
model
sar
use
vivopassag
sarscov
balbc
mice
found
viru
lethal
adult
mice
gener
excess
innat
immun
respons
induc
lethal
pulmonari
edema
diffus
alveolar
damag
infiltr
macrophag
neutrophil
appear
play
import
role
modul
innat
immun
respons
treatment
protect
anim
lethal
respiratori
ill
studi
along
previou
studi
studi
human
infect
sarscov
sar
epidem
winter
improv
understand
sar
pathogenesi
indic
advanc
age
viru
adapt
particular
anim
speci
may
dictat
pathogen
capac
sarscov
new
experiment
model
describ
may
also
use
elucid
pathophysiolog
sar
evalu
antisarscov
vaccin
candid
antivir
agent
